1
POSTER PRESENTATION Open Access Homozygous KIR2DL3 confers susceptibility to tuberculosis infection in HIV seropositive individuals Stalinraja Maruthamuthu 1 , Suresh Madasamy 2 , Jayalakshmi Mariakuttikan 1* From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014) Chennai, India. 30 January - 1 February 2014 Background Tuberculosis (TB) remains an important cause of death among patients infected with HIV. Genetic variation influences differential development of TB particularly in Immunosupressed patients. Natural Killer cells play an important role in the innate immune system by provid- ing the first line of defence against viral infections and tumors. Their activity is partially controlled by distinct inhibitory and activating killer Ig like receptors (KIR) that recognize specific ligands on potential target cells. Objective of this study is to determine the association between KIR and HIV co-infection. Methods This nested case control study comprised of 68 HIV+ individuals (34 treatment naive HIV-1 slow progressors and 34 on ART patients with TB co-infection). Genomic DNA was extracted from peripheral blood samples by salting out procedure and KIR genotyping was performed for 15 KIR genes (Activating and Inhibitory) by Multiplex PCR sequence specific primer method. Results All 15 KIR genes were observed in this study cohort. We could observe more number (>4 aKIR) of activating KIR genes in HIV+ TBindividuals (88%) when compared with HIV+ TB+ patients (74%). Homozygosity for KIR2DL3 was more frequent in HIV+ TB+ patients (64%) than HIV+ TBindividuals (32%) which may confer susceptibility to co-infection. Conclusion NK cell receptor KIRs limits HIV disease progression. In the present study, HIV positive individuals who were homozygous for inhibitory KIR2DL3 are at higher risk of acquiring TB co-infection and disease progression with decreased CD4 cells. Authorsdetails 1 Department of Immunology, School of Biological Sciences, Madurai Kamaraj University, Madurai- 625021, India. 2 ART Centre, Govt. Theni Medical College and Hospital, Theni, India. Published: 27 May 2014 doi:10.1186/1471-2334-14-S3-P67 Cite this article as: Maruthamuthu et al.: Homozygous KIR2DL3 confers susceptibility to tuberculosis infection in HIV seropositive individuals. BMC Infectious Diseases 2014 14(Suppl 3):P67. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit * Correspondence: [email protected] 1 Department of Immunology, School of Biological Sciences, Madurai Kamaraj University, Madurai- 625021, India Full list of author information is available at the end of the article Maruthamuthu et al. BMC Infectious Diseases 2014, 14(Suppl 3):P67 http://www.biomedcentral.com/1471-2334/14/S3/P67 © 2014 Maruthamuthu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Homozygous KIR2DL3 confers susceptibility to tuberculosis infection in HIV seropositive individuals

Embed Size (px)

Citation preview

Page 1: Homozygous KIR2DL3 confers susceptibility to tuberculosis infection in HIV seropositive individuals

POSTER PRESENTATION Open Access

Homozygous KIR2DL3 confers susceptibility totuberculosis infection in HIV seropositiveindividualsStalinraja Maruthamuthu1, Suresh Madasamy2, Jayalakshmi Mariakuttikan1*

From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014)Chennai, India. 30 January - 1 February 2014

BackgroundTuberculosis (TB) remains an important cause of deathamong patients infected with HIV. Genetic variationinfluences differential development of TB particularly inImmunosupressed patients. Natural Killer cells play animportant role in the innate immune system by provid-ing the first line of defence against viral infections andtumors. Their activity is partially controlled by distinctinhibitory and activating killer Ig like receptors (KIR)that recognize specific ligands on potential target cells.Objective of this study is to determine the associationbetween KIR and HIV co-infection.

MethodsThis nested case control study comprised of 68 HIV+individuals (34 treatment naive HIV-1 slow progressorsand 34 on ART patients with TB co-infection). GenomicDNA was extracted from peripheral blood samples bysalting out procedure and KIR genotyping was performedfor 15 KIR genes (Activating and Inhibitory) by MultiplexPCR sequence specific primer method.

ResultsAll 15 KIR genes were observed in this study cohort. Wecould observe more number (>4 aKIR) of activating KIRgenes in HIV+ TB– individuals (88%) when compared withHIV+ TB+ patients (74%). Homozygosity for KIR2DL3 wasmore frequent in HIV+ TB+ patients (64%) than HIV+TB– individuals (32%) which may confer susceptibility toco-infection.

ConclusionNK cell receptor KIRs limits HIV disease progression. Inthe present study, HIV positive individuals who werehomozygous for inhibitory KIR2DL3 are at higher risk ofacquiring TB co-infection and disease progression withdecreased CD4 cells.

Authors’ details1Department of Immunology, School of Biological Sciences, Madurai KamarajUniversity, Madurai- 625021, India. 2ART Centre, Govt. Theni Medical Collegeand Hospital, Theni, India.

Published: 27 May 2014

doi:10.1186/1471-2334-14-S3-P67Cite this article as: Maruthamuthu et al.: Homozygous KIR2DL3 conferssusceptibility to tuberculosis infection in HIV seropositive individuals.BMC Infectious Diseases 2014 14(Suppl 3):P67.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

* Correspondence: [email protected] of Immunology, School of Biological Sciences, Madurai KamarajUniversity, Madurai- 625021, IndiaFull list of author information is available at the end of the article

Maruthamuthu et al. BMC Infectious Diseases 2014, 14(Suppl 3):P67http://www.biomedcentral.com/1471-2334/14/S3/P67

© 2014 Maruthamuthu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the CreativeCommons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.